Breaking News

Charles River Launches eXpDNA Plasmid Platform

Reduces plasmid development and production timelines while streamlining the development journey for cell and gene therapy and vaccine developers.

Author Image

By: Charlie Sternberg

Associate Editor

Charles River Laboratories International Inc. has launched its eXpDNA plasmid platform, established from the company’s contract development and manufacturing (CDMO) and biologics testing experience.   The platform significantly reduces plasmid development and production timelines while streamlining the development journey for cell and gene therapy and vaccine developers with a focus on product quality and consistency.   The platform leverages Charles River’s expertise in developing, manufact...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters